Zoekresultaten
  1. 4 uur geleden

    What is required to demonstrate analytical similarity for compared to their reference products? Watch Dr. Steve Kozlowski explain the data requirements.

    1 antwoord 4 retweets 6 vind-ik-leuks
  2. 7 uur geleden

    ' provide the NHS with the prospect of saving millions of pounds, whilst also increasing access to important medicines'- looks at how adoption of the products can be sped up

  3. 8 uur geleden

    Check out these 2 FREE activities on to treat inflammatory diseases & in just 15 mins per webcast, you’ll gain new insights on these new treatment strategies & earn / credit. Find them (& more) on the Biosimilars Hub:

    2 retweets 1 vind-ik-leuk
  4. 8 uur geleden

    The End of Phase 3 Clinical Trials in Development?

    1 retweet 1 vind-ik-leuk
  5. 10 uur geleden
    Als antwoord op

    Most of the recent on issued by have been related to manufacturing facility short comings, rather than on the clinical/safety/physiochemical data. Can't say actually that the FDA regulatory requirements are stricter though.

    1 antwoord 3 vind-ik-leuks
  6. 10 uur geleden

    Thank you for your hard persistent work in getting this legislation signed! You absolutely rock! 👍🏼💙 Biosimilar Substitution Victories Across the Country! Now on to more states! 💪🏼

    2 antwoorden 4 retweets 5 vind-ik-leuks
  7. 28 jun.

    - agressieve marketing-campagne NL om meer te verkopen met die van jullie blockbuster-? moet groeien

    1 retweet 1 vind-ik-leuk
  8. 28 jun.

    Join Us! Submit your entry before 13th July for a chance to be recognized at this year . Celebrating the efforts made by the & industries, in making more affordable readily available to all. Enter:

    3 retweets 3 vind-ik-leuks
  9. 27 jun.

    IPCs Biosimilars@working group just finished an exciting day of presentations discussing a variety of topics. Looking forward to an updated manuscript from the team.

    2 retweets 9 vind-ik-leuks
  10. 27 jun.

    Lees over Congresnieuws, registraties en marktontwikkelingen op het gebied van in de van Biosimilars Nederland van juni 2018

    1 retweet 1 vind-ik-leuk
  11. 27 jun.

    Presentation by researchers of On topics addressed in the field of .

    3 retweets 4 vind-ik-leuks
  12. 27 jun.

    Jonathan Kay, MD presents current approved for at the IPC Biosimilars round table at in Stockholm.

    3 retweets 7 vind-ik-leuks
  13. 27 jun.

    in the real world - reports back from a discussion at the Congress 2018

    2 retweets 5 vind-ik-leuks
  14. 26 jun.

    ESNO Nurse Guide soon available in 7 languages.

    6 retweets 6 vind-ik-leuks
  15. 26 jun.

    The ESNO Nurses guide on Biosimilar is online at

    1 antwoord 11 retweets 14 vind-ik-leuks
  16. 26 jun.

    At the unveiling of the official “Switch Management between Similar Biological Medicines” for nurses by

    3 retweets 4 vind-ik-leuks
  17. 26 jun.

    - Global Regulatory Strategies for Biosimilars panelists agreed on need for global harmonization for distinct non-proprietary names

    3 retweets 4 vind-ik-leuks
  18. 26 jun.

    17 - 18 May New & - focus on & - macroregion in &

    4 retweets 2 vind-ik-leuks
  19. 26 jun.

    Medaxes participating in debate organised in . Supporting strong industry in Europe, creating pharma eco-systems to the benefit of European workers and their companies, whether , or manufacturing waiver

    2 retweets 7 vind-ik-leuks
  20. 25 jun.

    Learn about and the obstacles smaller companies face when trying to bring them to market in this session chaired by Oxana Iliach - tomorrow at 8am.

    4 retweets 2 vind-ik-leuks

Geen resultaten.

Het laden lijkt wat langer te duren.

Twitter is mogelijk overbelast of ondervindt een tijdelijke onderbreking. Probeer het opnieuw of bekijk de Twitter-status voor meer informatie.